BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, February 17, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 25, 2018
View Archived Issues
Interneurons to the spinal cord rescue
Read More
Kinase inhibitor restores chemo sensitivity
Read More
Selective SSTR4 receptor agonist presented for the treatment of Alzheimer's disease
Read More
New phase IIa study aims to confirm absence of anticholinergic effects with seliforant
Read More
BDNF gene therapy shows promising preclinical results and prepares for clinical trials
Read More
FDA approves Orilissa for moderate to severe endometriosis pain
Read More
RORgammaT antagonists described by Kaken Pharmaceutical, Meiji Seika Pharma
Read More
Aldeyra opens phase III trial of topical reproxalap to treat ichthyosis in Sjogren-Larsson syndrome
Read More
SSAO inhibitors identified at Ube Industries
Read More
Purdue Pharma patents mu-opioid receptor and/or kappa-opioid receptor agonists
Read More
Shanghai Longwood Biopharmaceuticals presents agents for HBV infection
Read More
Roche, Genentech describe new JAK1 inhibitors
Read More
Biohaven begins phase II/III study of trigriluzole for mild to moderate Alzheimer's disease
Read More
Sienna reports phase Ib maximal use safety data on SNA-120 for pruritus in psoriasis
Read More
FDA accepts Celyad's IND for non-gene edited allogeneic CAR-T candidate CYAD-101
Read More
Stress-induced depression depends on innate immunity
Read More
Minomic completes dosing in first-in-human study of miltuximab
Read More
KEYNOTE-48 trial of Keytruda meets OS primary endpoint in head and neck cancer
Read More
Novel gene therapy demonstrates efficacy in preclinical models of neurodegenerative disease
Read More